InMed Pharmaceuticals INM
NASDAQ INM
$1.33 -0.02 (-1.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

InMed Pharmaceuticals (INM) Cost of Revenue (2021 - 2025)

Updated

InMed Pharmaceuticals' Cost of Revenue came in at $635,994 for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 2.3% from $650,813 a year earlier and down 11.3% from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Cost of Revenue (2021 - 2025) Analysis & Trends

Over the trailing twelve months to Dec 31, 2025, InMed Pharmaceuticals reported Cost of Revenue of $3.17 million, up 1.4% year-over-year; for FY2025 (ended Jun 30, 2025), it came in at $3.24 million, down 7.5% from FY2024.

  • Cost of Revenue carries a three-year compound annual growth rate of 81.0% (FY2022 to FY2025).
  • Going back by fiscal year, Cost of Revenue was $3.5 million in FY2024 (+28.0%), $2.73 million in FY2023 (+400.6%) and $545,889 in FY2022.
  • The fiscal Q2 2026 figure represents the lowest quarterly Cost of Revenue since fiscal Q2 2023.
  • Year-over-year, Cost of Revenue has declined for three consecutive quarters, with an average decline of 9.0% over the last eight quarters.
  • The fastest year-over-year change in Cost of Revenue over five years came in fiscal Q3 2023 (growth of 560.9%), and the weakest in fiscal Q4 2024 (a decline of 38.0%).
  • Business Quant data shows INM's Cost of Revenue at $716,962 (Q1 2026), $728,056 (Q4 2025) and $1.09 million (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Linde 221.03 Bn 204.14 Bn 4.43 Bn 4.86 Bn
2 Corning 141.47 Bn 134.60 Bn 1.63 Bn 2.88 Bn
3 Sherwin Williams 77.59 Bn 76.63 Bn 3.34 Bn 3.45 Bn
4 Air Products & Chemicals 61.84 Bn 59.74 Bn 1.04 Bn 2.13 Bn
5 LyondellBasell Industries 37.84 Bn 27.46 Bn 2.04 Bn 7.14 Bn
6 Nutrien 33.77 Bn 30.64 Bn 3.25 Bn 7.36 Bn
7 Qnity Electronics 27.51 Bn 24.93 Bn 666.00 Mn 763.00 Mn
8 Ati 26.21 Bn 24.36 Bn 309.80 Mn 951.30 Mn
9 Ppg Industries 23.37 Bn 16.17 Bn 1.81 Bn 2.69 Bn
10 InMed Pharmaceuticals 5.54 Mn 3.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 635,994.00
Sep 30, 2025 716,962.00
Jun 30, 2025 728,056.00
Mar 31, 2025 1.09 Mn
Dec 31, 2024 650,813.00
Sep 30, 2024 771,225.00
Jun 30, 2024 816,996.00
Mar 31, 2024 883,143.00
Dec 31, 2023 916,058.00
Sep 30, 2023 880,620.00
Jun 30, 2023 1.32 Mn
Mar 31, 2023 841,414.00
Dec 31, 2022 338,620.00
Sep 30, 2022 235,034.00
Jun 30, 2022 265,044.00
Mar 31, 2022 127,308.00
Dec 31, 2021 153,537.00
API Access

InMed Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=INM&period=max&api_key=YOUR_API_KEY